“PHARMACOTHERAPEUTIC USE OF THE MEDICATION LEVOMEPROMAZINE HYCLORIDATE IN CHILDREN AGED 4 TO 10 YEARS OLD WITH AUTISTIC SPECTRUM DISORDER (ASD): A BIBLIOGRAPHICAL REVIEW”, RECIMA21, vol. 5, no. 5, p. e555210, May 2024, doi: 10.47820/recima21.v5i5.5210.